Cargando…
Targeting CD36 as Biomarker for Metastasis Prognostic: How Far from Translation into Clinical Practice?
Metastasis requires cellular changes related to cell-to-cell and cell-to-matrix adhesion, immune surveillance, activation of growth and survival signalling pathways, and epigenetic modifications. In addition to tumour cells, tumour stroma is also modified in relationship to the primary tumour as wel...
Autores principales: | Enciu, Ana-Maria, Radu, Eugen, Popescu, Ionela Daniela, Hinescu, Mihail Eugen, Ceafalan, Laura Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6057354/ https://www.ncbi.nlm.nih.gov/pubmed/30069479 http://dx.doi.org/10.1155/2018/7801202 |
Ejemplares similares
-
CD 36: Focus on Epigenetic and Post-Transcriptional Regulation
por: Niculite, Cristina-Mariana, et al.
Publicado: (2019) -
CD36 and CD97 in Pancreatic Cancer versus Other Malignancies
por: Tanase, Cristiana, et al.
Publicado: (2020) -
CD36 – A novel molecular target in the neurovascular unit
por: Ioghen, Octavian, et al.
Publicado: (2021) -
Fatty Acids, CD36, Thrombospondin-1, and CD47 in Glioblastoma: Together and/or Separately?
por: Tanase, Cristiana, et al.
Publicado: (2022) -
Cellular Players in Skeletal Muscle Regeneration
por: Ceafalan, Laura Cristina, et al.
Publicado: (2014)